Abstract

Recently we demonstrated that the ability of tumor necrosis factor alpha (TNFalpha) to stimulate the human cytomegalovirus (HCMV) IE1/2 enhancer/promoter activity in myeloid progenitor-like cells decreases when these cells differentiate into promonocytic cells. In addition, TNFalpha stimulation in the progenitor-like cell line HL-60 was shown to be mediated by nuclear factor kappaB (NF-kappaB) activation and its binding to the 18-base pair sequence motifs of the IE1/2 enhancer. We demonstrate here that the cell differentiation-dependent reduction of TNFalpha stimulation is not due to insufficient NF-kappaB activation but correlates with increased synthesis of the monocyte differentiation-associated factors CCAAT/enhancer-binding protein (C/EBP) alpha and beta. Overexpression of C/EBPalpha/beta in HL-60 cells, which normally produce only very small amounts of C/EBP, stimulated the basal activity of the promoter in the absence of NF-kappaB but suppressed the stimulatory effect of TNFalpha. A novel C/EBP-binding site was identified in the IE1/2 enhancer directly downstream of a NF-kappaB site. In order to understand the mechanisms of interaction, we used an IE1/2 promoter mutant that failed to bind C/EBP at this position and several constructs that contained exclusively NF-kappaB- and/or C/EBP-binding sites upstream of the minimal IE1/2 promoter. We could demonstrate that C/EBPalpha/beta interacts with NF-kappaB p65 and displays inhibitory activity even in the absence of direct DNA binding by forming p65-C/EBP-containing protein complexes bound to the NF-kappaB site. Moreover, C/EBP binding to the DNA adjacent to NF-kappaB supports the down-regulatory effect of C/EBPs possibly due to stabilization of a multimeric NF-kappaB-C/EBP complex. Our results show that cell differentiation factors may interfere with TNFalpha-induced human cytomegalovirus gene (re)activation.

Highlights

  • Megalovirus (HCMV) IE1/2 enhancer/promoter activity (TNF␣) has been identified as a powerful mediator of human cytomegalovirus (HCMV) in myeloid progenitor-like cells decreases when these stimulation and reactivation in human and murine monocyte/

  • We could demonstrate that CCAAT/enhancerbinding protein (C/EBP-binding site (EBP))␣/␤ interacts with nuclear factor ␬B (NF-␬B) p65 and displays inhibitory activity even in the absence of direct DNA binding by forming p65-C/EBP-containing protein complexes bound to the NF-␬B site

  • This TNF␣-induced signal transduction pathway was identified in U937 and THP-1 cells indicating that the observed differentiation-dependent changes in TNF␣-mediated regulation of the HCMV IE1/2 enhancer/promoter cannot be explained by decreased activation of NF-␬B p65/p50

Read more

Summary

EXPERIMENTAL PROCEDURES

Cell Culture, Transfection, and CAT Assays—The cell lines HL-60, U937, and THP-1 (ATCC CCL 240, CRL 1593 and TIB 202) were maintained in RPMI 1640 medium (Biochrom, Berlin, Germany) supplemented with 10% fetal calf serum (both certified for low endotoxin). Transfection efficacy of different plasmids was determined by dot blot hybridization of DNA isolated from comparable cell extracts (identical protein concentration) with a 32P-labeled BamHI-DNA fragment of plasmid pRR55 containing the CAT gene as described previously [15]. The plasmid p4-18PCAT carries the minimal IE1/2 promoter between positions Ϫ52 and ϩ52 in combination with four in-tandem copies of the 18-bp repetitive sequence motif of the IE1/2 enhancer upstream of the CAT gene [40]. Both plasmids were kindly provided by T. Cambridge, UK, contain the coding sequences for NF-␬B p65 and p50, respectively, under control of the CMV promoter in the pcDNA3 vector

Nucleotide sequence
RESULTS
DISCUSSION
By EMSA and Western blot analysis we could demonstrate

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.